The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy...
Approves
Descrease article font size Increase article font size Health Canada has approved a new treatment for adults with recurrent or...
The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to Perjeta (pertuzumab) for patients...
The FDA recently approved Teal Wand, the first at-home, vaginal, self-collection device for cervical cancer screening, according to a news...
